• Protective Genes Against Alzheimer’s Disease: Case Review and Therapeutic Implications
• Protective Genes Against Alzheimer’s Disease: Case Review and Therapeutic Implications
• Nabiha Hossain ,1 Yong Jeong 1,2,3

Dementia and Neurocognitive Disorders 2025; 24: 75 - 90

• Reproducibility of Plasma Biomarker Measurements Across Laboratories: Insights Into ptau217, GFAP, and NfL
• Reproducibility of Plasma Biomarker Measurements Across Laboratories: Insights Into ptau217, GFAP, and NfL
• Heekyoung Kang ,1 Sook-Young Woo ,2 Daeun Shin ,1 Sohyun Yim ,1 Eun Hye Lee ,1 Hyunchul Ryu ,3 Bora Chu ,3 Henrik Zetterberg ,4,5,6,7,8,9 Kaj Blennow ,4,5,10,11 Jihwan Yun ,12 Duk L Na ,13 Hee Jin Kim ,1,14,15,16 Hyemin Jang ,17 Jun Pyo Kim ,1 on behalf of the K-ROAD Study Groups

Dementia and Neurocognitive Disorders 2025; 24: 91 - 101

• Comprehensive Clinical and Behavioral Characteristics of Mild Cognitive Impairment According to Amyloid Positivity: A Large Multi-Center Korean Cohort
• Comprehensive Clinical and Behavioral Characteristics of Mild Cognitive Impairment According to Amyloid Positivity: A Large Multi-Center Korean Cohort
• Seung Ae Kim , 1,2 Yeshin Kim ,3 Duk L. Na ,4,5 Sang Won Seo ,4,6,7,8,9 Hyemin Jang ,1 on behalf of PREMIER Consortium 

Dementia and Neurocognitive Disorders 2025; 24: 102 - 114

• Quantifying Brain Atrophy Using a CSF-Focused Segmentation Approach
• Quantifying Brain Atrophy Using a CSF-Focused Segmentation Approach
• Kyoung Yoon Lim ,1 Seongbeom Park ,1 Duk L. Na ,1 Sang Won Seo ,2,3,4,5 Min Young Chun ,6,7 Kichang Kwak ,1 on behalf of the K-ROAD study and ADNI

Dementia and Neurocognitive Disorders 2025; 24: 115 - 125

• Cognitive Impairment Screening Test in Korea as a Screening Tool for Dementia: The Correlation Study of Subtest Scores With Korean Version of the Mini Mental State Examination 2nd Edition
• Cognitive Impairment Screening Test in Korea as a Screening Tool for Dementia: The Correlation Study of Subtest Scores With Korean Version of the Mini Mental State Examination 2nd Edition
• Minseong Kim ,1 Doyun Heo ,1 Seonkyeong Kim ,1 Yunjin Lee ,1 Yong Sung Kim ,2 Wonjae Sung ,2 Hee-Jin Kim ,2

Dementia and Neurocognitive Disorders 2025; 24: 126 - 134

• Establishing Regional Aβ Cutoffs and Exploring Subgroup Prevalence Across Cognitive Stages Using BeauBrain Amylo®
• Establishing Regional Aβ Cutoffs and Exploring Subgroup Prevalence Across Cognitive Stages Using BeauBrain Amylo®
• Seongbeom Park ,1,* Kyoungmin Kim ,2,* Soyeon Yoon ,2 Seongmi Kim ,2 Jehyun Ahn ,2 Kyoung Yoon Lim ,1 Hyemin Jang ,3 Duk L. Na ,1,4 Hee Jin Kim ,2,5,6,7,8 Seung Hwan Moon ,9 Jun Pyo Kim ,5 Sang Won Seo ,2,5,6,7,8 Jaeho Kim ,10 Kichang Kwak  1

Dementia and Neurocognitive Disorders 2025; 24: 135 - 146